1.030000 EUR
0.1
8.85%
Last update Dec 16, 7:37 PM CET
Main market
Day range
1.030000
1.030000
Previous close
1.13000
Open
1.030000
Access this stock data via API
Subscribe
Interpace Biosciences, Inc.
1.03
0.10
8.85%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 40.0M 40.2M 31.8M 33.1M
Cost of revenue 14.5M 16.3M 13.6M 14.3M
Gross profit 25.5M 23.9M 18.2M 18.8M
Operating expense
Research & development 576.1K 636K 703K 1.5M
Selling general and admin 18.0M 19.6M 20.1M 19.9M
Other operating expenses
Operating income 6.9M 2.8M -3.8M -5.8M
Non operating interest income
Income
Expense 561.6K 1.0M 1.0M 1.0M
Other income expense -425.3K -674K -988K -938K
Pretax income 5.9M 1.1M -5.8M -7.7M
Tax provision 3.4K 17K 29K -705K
Net income 5.7M 802K -22.0M -14.9M
Basic EPS 1.4 0.2 -5.2 -3.6
Diluted EPS 0.4 0.2 -5.2 -3.6
Basic average shares 3.7M 4.7M 4.4M 4.3M
Diluted average shares 3.7M 4.7M 4.4M 4.3M
EBITDA 7.1M 3.7M -1.5M -769K
Net income from continuing op. 5.7M 802K -22.0M -14.9M
Minority interests
Preferred stock dividends 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 11 hours 45 minutes

08:14
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).